Biomerica Stock (NASDAQ: BMRA) stock price, news, charts, stock research, profile.
Open | $0.750 |
Close | $0.730 |
Volume / Avg. | 35.160K / 57.310K |
Day Range | 0.730 - 0.775 |
52 Wk Range | 0.704 - 2.130 |
Market Cap | $12.285M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 0.43% |
Days to Cover | 1.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biomerica (NASDAQ: BMRA) through any online brokerage.
Other companies in Biomerica’s space includes: Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Venus Concept (NASDAQ:VERO), Talis Biomedical (NASDAQ:TLIS) and QT Imaging Holdings (NASDAQ:QTI).
The latest price target for Biomerica (NASDAQ: BMRA) was reported by Aegis Capital on Monday, October 19, 2020. The analyst firm set a price target for 11.00 expecting BMRA to rise to within 12 months (a possible 1406.23% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Biomerica (NASDAQ: BMRA) is $0.7303 last updated April 19, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Biomerica.
Biomerica’s Q3 earnings are confirmed for Friday, April 12, 2024.
There is no upcoming split for Biomerica.
Biomerica is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.